TP53 and breast cancer: Applying machine learning to a large BC dataset reveals a subset of ER+Her2‐ tumors (pseudomutant p53 tumors) which, despite retaining wt p53, display gene expression and pathway deregulation profiles typical of p53‐mutated tumors, correlating with bad prognosis.